Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 68019904 | 6801990 | 4 | F | 20080524 | 20160823 | 20081103 | 20160823 | EXP | JP-BRISTOL-MYERS SQUIBB COMPANY-14385546 | BRISTOL MYERS SQUIBB | 0.00 | DY | Y | 0.51000 | KG | 20160823 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 68019904 | 6801990 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Transplacental | 6 MG, TID | U | 21436 | 6 | MG | TABLET | TID | |||||
| 68019904 | 6801990 | 2 | C | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | Transplacental | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 68019904 | 6801990 | 1 | Product used for unknown indication |
| 68019904 | 6801990 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 68019904 | 6801990 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 68019904 | 6801990 | Foetal exposure during pregnancy | |
| 68019904 | 6801990 | Premature baby |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 68019904 | 6801990 | 1 | 20080513 | 20080524 | 0 | |
| 68019904 | 6801990 | 2 | 20080524 | 0 |